Published in Carbohydr Res on July 01, 1986
Investigation of the structural heterogeneity of lipooligosaccharides from pathogenic Haemophilus and Neisseria species and of R-type lipopolysaccharides from Salmonella typhimurium by electrospray mass spectrometry. J Bacteriol (1993) 1.81
Use of synthetic antigens to determine the epitope specificities of monoclonal antibodies against the 3-deoxy-D-manno-octulosonate region of bacterial lipopolysaccharide. Infect Immun (1987) 1.11
Identification of phosphorylated 3-deoxy-manno-octulosonic acid as a component of Haemophilus influenzae lipopolysaccharide. Biochem J (1987) 1.00
Dissociation of cell-associated interleukin-1 (IL-1) and IL-1 release induced by lipopolysaccharide and lipid A. Infect Immun (1989) 0.87
Inhibition of exogenous 3-deoxy-D-manno-octulosonate incorporation into lipid A precursor of toluene-treated Salmonella typhimurium cells. J Bacteriol (1987) 0.86
The chemical composition of endotoxin isolated from intestinal strain of Desulfovibrio desulfuricans. ScientificWorldJournal (2012) 0.78
Modulating LPS signal transduction at the LPS receptor complex with synthetic Lipid A analogues. Adv Carbohydr Chem Biochem (2014) 0.77
Specificity of rabbit antisera against the rough lipopolysaccharide of Salmonella minnesota R4 (chemotype Rd2P-) Infect Immun (1993) 0.77
[Lipopolysaccharides, endotoxins and O-antigens of gram-negative bacteria: chemical structure, biologic effect and serologic properties]. Infection (1987) 0.75
Nature and linkages of the fatty acids present in the lipid-A component of Salmonella lipopolysaccharides. Eur J Biochem (1972) 4.15
Interaction of lipopolysaccharides and lipid A with complement. Eur J Biochem (1971) 4.15
Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities. Eur J Biochem (1985) 3.76
Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res (2001) 3.46
Biological activities of lipid A complexed with bovine-serum albumin. Eur J Biochem (1972) 3.04
Characterization of the lipopolysaccharide from the polymyxin-resistant pmrA mutants of Salmonella typhimurium. FEBS Lett (1981) 2.91
Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin. Carbohydr Res (1988) 2.55
IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol (1989) 2.41
A lethal role for lipid A in Salmonella infections. Mol Microbiol (1998) 2.30
Differential determination of the 3-Deoxy-D-mannooctulosonic acid residues in lipopolysaccharides of Salmonella minnesota rough mutants. Eur J Biochem (1983) 2.12
Bacterial endotoxins. Sci Am (1992) 2.00
Molecular mechanisms of endotoxin activity. Arch Microbiol (1995) 1.98
Isolation and analysis of the lipid A backbone. Lipid A structure of lipopolysaccharides from various bacterial groups. Eur J Biochem (1976) 1.87
Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur J Biochem (2000) 1.85
High state of order of isolated bacterial lipopolysaccharide and its possible contribution to the permeation barrier property of the outer membrane. J Bacteriol (1985) 1.85
Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification. Curr Top Microbiol Immunol (1996) 1.85
Lipopolysaccharide nomenclature--past, present, and future. J Bacteriol (1986) 1.80
Lipid A: chemical structure and biological activity. J Infect Dis (1973) 1.73
Chemical structure of the lipopolysaccharide of Haemophilus influenzae strain I-69 Rd-/b+. Description of a novel deep-rough chemotype. Eur J Biochem (1988) 1.73
Chemical structure and biological activities of lipid A's from various bacterial families. Naturwissenschaften (1978) 1.69
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
The chemical structure of lipid A. Demonstration of amide-linked 3-acyloxyacyl residues in Salmonella minnesota Re lipopolysaccharide. Eur J Biochem (1982) 1.67
Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A. Infect Immun (1992) 1.61
Soluble peptidoglycan-induced monokine production can be blocked by anti-CD14 monoclonal antibodies and by lipid A partial structures. Infect Immun (1994) 1.59
Biological activities of synthetic lipid A analogs: pyrogenicity, lethal toxicity, anticomplement activity, and induction of gelation of Limulus amoebocyte lysate. Infect Immun (1984) 1.59
Bacterial endotoxins: chemical structure, biological activity and role in septicaemia. Scand J Infect Dis Suppl (1982) 1.56
Prostaglandin and thromboxane synthesis in a pure macrophage population and the inhibition, by E-type prostaglandins, of chemiluminescence. FEBS Lett (1978) 1.55
Chemical structure of the lipid A component of the lipopolysaccharide from a Proteus mirabilis Re-mutant. Eur J Biochem (1983) 1.54
Fatal granuloma necrosis without exacerbated mycobacterial growth in tumor necrosis factor receptor p55 gene-deficient mice intravenously infected with Mycobacterium avium. Infect Immun (1999) 1.52
Deletion of the heptosyltransferase genes rfaC and rfaF in Escherichia coli K-12 results in an Re-type lipopolysaccharide with a high degree of 2-aminoethanol phosphate substitution. Eur J Biochem (1997) 1.51
Immunogenic properties of lipid A. Rev Infect Dis (1984) 1.51
The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment. Infect Immun (1987) 1.49
A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides. Infect Immun (1993) 1.49
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Structural characterization of the lipid A component of pathogenic Neisseria meningitidis. J Bacteriol (1992) 1.46
Structure-activity relationships of bacterial lipopolysaccharides (endotoxins). Current and future aspects. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 1.46
Structural characterization of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem (1989) 1.42
Chemical and serological investigations on the genus-specific lipopolysaccharide epitope of Chlamydia. Proc Natl Acad Sci U S A (1987) 1.40
Specific binding of soluble peptidoglycan and muramyldipeptide to CD14 on human monocytes. Infect Immun (1997) 1.40
Isolation, purification, and chemical analysis of the lipopolysaccharide and lipid A of Acinetobacter calcoaceticus NCTC 10305. Eur J Biochem (1982) 1.39
Chemical, biological, and immunochemical properties of the Chlamydia psittaci lipopolysaccharide. Infect Immun (1986) 1.38
Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin. Infect Immun (1973) 1.38
Chemical structure of glycosphingolipids isolated from Sphingomonas paucimobilis. FEBS Lett (1991) 1.37
The lipopolysaccharide of Legionella pneumophila serogroup 1 (strain Philadelphia 1): chemical structure and biological significance. Prog Clin Biol Res (1995) 1.37
Induction of human interleukin 1 by bacterial and synthetic lipid A. Eur J Immunol (1986) 1.36
Chemical characterization of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.36
Biological activities of chemically modified endotoxins. Eur J Biochem (1971) 1.36
Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res (1987) 1.35
Antigenic properties of Chlamydia trachomatis lipopolysaccharide. Infect Immun (1985) 1.34
Concepts of the chemical structure of lipid A. Rev Infect Dis (1984) 1.34
Stimulation of human T lymphocytes by LPS is MHC unrestricted, but strongly dependent on B7 interactions. J Immunol (1998) 1.34
Alpha-2----4-interlinked 3-deoxy-D-manno-octulosonic acid disaccharide. A common constituent of enterobacterial lipopolysaccharides. Eur J Biochem (1984) 1.33
Endotoxic properties of chemically synthesized lipid A part structures. Comparison of synthetic lipid A precursor and synthetic analogues with biosynthetic lipid A precursor and free lipid A. Eur J Biochem (1984) 1.33
Serological cross-reactions between Acinetobacter calcoaceticus and chlamydiae. J Clin Microbiol (1979) 1.31
Molecular structure of lipid A, the endotoxic center of bacterial lipopolysaccharides. Adv Carbohydr Chem Biochem (1994) 1.31
Tertiary structure of Staphylococcus aureus cell wall murein. J Bacteriol (2004) 1.27
The charge of endotoxin molecules influences their conformation and IL-6-inducing capacity. J Immunol (1998) 1.27
Lipopolysaccharide biosynthesis: which steps do bacteria need to survive? J Endotoxin Res (2001) 1.26
A synthetic glycoconjugate representing the genus-specific epitope of chlamydial lipopolysaccharide exhibits the same specificity as its natural counterpart. Infect Immun (1992) 1.23
Lipid A antiserum-mediated protection against lipopolysaccharide- and lipid A-induced fever and skin necrosis. Infect Immun (1977) 1.23
Structural characterization of the lipid A component of Pseudomonas aeruginosa wild-type and rough mutant lipopolysaccharides. Eur J Biochem (1991) 1.23
Specificity of rabbit antisera against lipopolysaccharide of Acinetobacter. J Clin Microbiol (1998) 1.22
Lipopolysaccharides: structural principles and biologic activities. Rev Infect Dis (1984) 1.22
Nature, type of linkage, quantity, and absolute configuration of (3-hydroxy) fatty acids in lipopolysaccharides from Bacteroides fragilis NCTC 9343 and related strains. J Bacteriol (1980) 1.21
Gonococcal rfaF mutants express Rd2 chemotype LPS and do not enter epithelial host cells. Mol Microbiol (1995) 1.21
Biological activities of lipopolysaccharides and lipid A from Rhodospirillaceae. Infect Immun (1977) 1.21
Biological activity of synthetic phosphonooxyethyl analogs of lipid A and lipid A partial structures. Infect Immun (1992) 1.20
Occurrence of antibodies against chlamydial lipopolysaccharide in human sera as measured by ELISA using an artificial glycoconjugate antigen. FEMS Immunol Med Microbiol (1994) 1.20
Lipopolysaccharide-binding protein mediates CD14-independent intercalation of lipopolysaccharide into phospholipid membranes. FEBS Lett (1996) 1.19
Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli. Infect Immun (1985) 1.19
Architecture of the outer membrane of Escherichia coli K12. Phase transitions of the bacteriophage K3 receptor complex. Eur J Biochem (1979) 1.18
Common lipopolysaccharide specificity: new type of antigen residing in the inner core region of S- and R-form lipopolysaccharides from different families of gram-negative bacteria. Infect Immun (1983) 1.18
A 28 kDa protein of normal mouse serum binds lipopolysaccharides of gram-negative and lipoteichoic acids of gram-positive bacteria. Microb Pathog (1990) 1.18
NOS2-derived nitric oxide regulates the size, quantity and quality of granuloma formation in Mycobacterium avium-infected mice without affecting bacterial loads. Immunology (1999) 1.17
Nature, type of linkage, and absolute configuration of (hydroxy) fatty acids in lipopolysaccharides from Xanthomonas sinensis and related strains. J Bacteriol (1975) 1.16
Molecular requirement for interleukin 1 induction by lipopolysaccharide-stimulated human monocytes: involvement of the heptosyl-2-keto-3-deoxyoctulosonate region. Eur J Immunol (1986) 1.15
Endotoxins of Gram-negative bacteria. Pharmacol Ther (1981) 1.14
Occurrence of 2-keto-deoxyoctonic acid 5-phosphate in lipopolysaccharides of Vibrio cholerae Ogawa and Inaba. J Bacteriol (1985) 1.14
The structure of the O-specific chain of Legionella pneumophila serogroup 1 lipopolysaccharide. Eur J Biochem (1994) 1.14
Biochemistry and cell biology of bacterial endotoxins. FEMS Immunol Med Microbiol (1996) 1.13
Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency. Immunology (1973) 1.13
Endotoxin and lipid A stimulate proliferation of human T cells in the presence of autologous monocytes. J Immunol (1994) 1.13